New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays - PubMed (original) (raw)
. 2001 Nov 15;61(22):8235-40.
Affiliations
- PMID: 11719455
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays
P Kauraniemi et al. Cancer Res. 2001.
Abstract
Amplification of the ERBB2 oncogene at 17q12 has been well documented in breast cancer and has been shown to contribute to a poor clinical outcome. However, systematic surveys of copy number and expression levels of all genes within the 17q12 region have not been performed. Here, we used cDNA and comparative genomic hybridization microarray technologies to undertake a broad survey of genes involved in the 17q12 amplification in breast cancer. A chromosomal region-specific cDNA microarray containing 217 expressed sequence tag (EST) clones from 17q12 was constructed and used for parallel analysis of gene copy numbers and expression levels in seven breast cancer cell lines allowing direct identification of genes whose expression is elevated because of an increase in copy number in this chromosomal region. The copy number and expression survey identified 12 transcripts that showed a consistent pattern of increased copy number and expression in three or more of the 17q12-amplified cell lines. As expected, these included ERBB2 as well as the GRB7 and MLN64 genes previously shown to be coamplified with ERBB2. In addition, five other known genes and four uncharacterized ESTs were also found to be consistently activated by amplification in these breast cancer cell lines. Amplicon mapping by fluorescence in situ hybridization revealed a minimal common region of amplification containing four highly expressed genes, ERBB2, GRB7, MLN64, and an uncharacterized EST 48582. Furthermore, several other genes, although not located in the minimal common region of amplification, showed a correlated pattern of amplification and expression indicating that they might play a role in breast cancers with the 17q12 amplification. In conclusion, parallel analysis of gene copy number and expression levels by cDNA microarray can be used to directly identify candidate target genes involved in amplifications. Our results show that the 17q12 amplification in breast cancer leads to the simultaneous elevation of expression levels of several genes.
Similar articles
- RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
Kao J, Pollack JR. Kao J, et al. Genes Chromosomes Cancer. 2006 Aug;45(8):761-9. doi: 10.1002/gcc.20339. Genes Chromosomes Cancer. 2006. PMID: 16708353 - Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE. Willis S, et al. Genes Chromosomes Cancer. 2003 Apr;36(4):382-92. doi: 10.1002/gcc.10138. Genes Chromosomes Cancer. 2003. PMID: 12619162 - Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA, Baras A, Malinowski R, Alvis LB, Kwon I, Walz TM, Polymeropoulos MH. Dressman MA, et al. Cancer Res. 2003 May 1;63(9):2194-9. Cancer Res. 2003. PMID: 12727839 - Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
Kauraniemi P, Kallioniemi A. Kauraniemi P, et al. Endocr Relat Cancer. 2006 Mar;13(1):39-49. doi: 10.1677/erc.1.01147. Endocr Relat Cancer. 2006. PMID: 16601278 Review. - National Oncology Forum: perspectives for the year 2000.
DeVita VT Jr, Bleickardt EW. DeVita VT Jr, et al. Cancer J. 2001 Jul-Aug;7 Suppl 1:S2-13. Cancer J. 2001. PMID: 11504281 Review.
Cited by
- Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways.
Khan F, Elsori D, Verma M, Pandey S, Obaidur Rab S, Siddiqui S, Alabdallah NM, Saeed M, Pandey P. Khan F, et al. Front Cell Dev Biol. 2024 Jun 12;12:1399065. doi: 10.3389/fcell.2024.1399065. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38933330 Free PMC article. Review. - CMGC Kinases in Health and Cancer.
Chowdhury I, Dashi G, Keskitalo S. Chowdhury I, et al. Cancers (Basel). 2023 Jul 28;15(15):3838. doi: 10.3390/cancers15153838. Cancers (Basel). 2023. PMID: 37568654 Free PMC article. Review. - Contribution of PGAP3 co-amplified and co-overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer.
Wang D, Hao S, He H, Zhang J, You G, Wu X, Zhang R, Meng X, Cui X, Bai J, Fu S, Yu J. Wang D, et al. J Cell Mol Med. 2023 Aug;27(16):2424-2436. doi: 10.1111/jcmm.17828. Epub 2023 Jun 29. J Cell Mol Med. 2023. PMID: 37386793 Free PMC article. - Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.
Nguyen MKL, Jose J, Wahba M, Bernaus-Esqué M, Hoy AJ, Enrich C, Rentero C, Grewal T. Nguyen MKL, et al. Int J Mol Sci. 2022 Jun 29;23(13):7206. doi: 10.3390/ijms23137206. Int J Mol Sci. 2022. PMID: 35806209 Free PMC article. Review. - Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer.
Yang Y, Leonard M, Luo Z, Yeo S, Bick G, Hao M, Cai C, Charif M, Wang J, Guan JL, Lower EE, Zhang X. Yang Y, et al. Cell Rep. 2021 Mar 9;34(10):108822. doi: 10.1016/j.celrep.2021.108822. Cell Rep. 2021. PMID: 33691110 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous